BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 12875986)

  • 1. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy.
    Pontén A; Li X; Thorén P; Aase K; Sjöblom T; Ostman A; Eriksson U
    Am J Pathol; 2003 Aug; 163(2):673-82. PubMed ID: 12875986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor D induces cardiac fibrosis and proliferation of vascular smooth muscle cells in heart-specific transgenic mice.
    Pontén A; Folestad EB; Pietras K; Eriksson U
    Circ Res; 2005 Nov; 97(10):1036-45. PubMed ID: 16224065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
    Ishimaru K; Miyagawa S; Fukushima S; Saito A; Sakai Y; Ueno T; Sawa Y
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophy.
    Cañes L; Martí-Pàmies I; Ballester-Servera C; Herraiz-Martínez A; Alonso J; Galán M; Nistal JF; Muniesa P; Osada J; Hove-Madsen L; Rodríguez C; Martínez-González J
    Clin Sci (Lond); 2020 Feb; 134(3):359-377. PubMed ID: 31985010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.
    Karpanen T; Bry M; Ollila HM; Seppänen-Laakso T; Liimatta E; Leskinen H; Kivelä R; Helkamaa T; Merentie M; Jeltsch M; Paavonen K; Andersson LC; Mervaala E; Hassinen IE; Ylä-Herttuala S; Oresic M; Alitalo K
    Circ Res; 2008 Oct; 103(9):1018-26. PubMed ID: 18757827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6.
    Ohkura SI; Usui S; Takashima SI; Takuwa N; Yoshioka K; Okamoto Y; Inagaki Y; Sugimoto N; Kitano T; Takamura M; Wada T; Kaneko S; Takuwa Y
    PLoS One; 2017; 12(8):e0182329. PubMed ID: 28771545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Biomarker and Imaging Analysis for Characterizing Progressive Cardiac Fibrosis in a Mouse Model of Chronic Chagasic Cardiomyopathy.
    Hoffman KA; Reynolds C; Bottazzi ME; Hotez P; Jones K
    J Am Heart Assoc; 2019 Nov; 8(22):e013365. PubMed ID: 31718442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy.
    Nebigil CG; Jaffré F; Messaddeq N; Hickel P; Monassier L; Launay JM; Maroteaux L
    Circulation; 2003 Jul; 107(25):3223-9. PubMed ID: 12810613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage.
    Urayama K; Dedeoglu DB; Guilini C; Frantz S; Ertl G; Messaddeq N; Nebigil CG
    Cardiovasc Res; 2009 Jan; 81(1):28-37. PubMed ID: 18806277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between the E2F pathway and β-adrenergic signaling in the pathological hypertrophic response of myocardium.
    Major JL; Salih M; Tuana BS
    J Mol Cell Cardiol; 2015 Jul; 84():179-90. PubMed ID: 25944088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDGF mediates cardiac microvascular communication.
    Edelberg JM; Aird WC; Wu W; Rayburn H; Mamuya WS; Mercola M; Rosenberg RD
    J Clin Invest; 1998 Aug; 102(4):837-43. PubMed ID: 9710453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac-specific PID1 overexpression enhances pressure overload-induced cardiac hypertrophy in mice.
    Liu Y; Shen Y; Zhu J; Liu M; Li X; Chen Y; Kong X; Song G; Qian L
    Cell Physiol Biochem; 2015; 35(5):1975-85. PubMed ID: 25871431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct functions of junD in cardiac hypertrophy and heart failure.
    Ricci R; Eriksson U; Oudit GY; Eferl R; Akhmedov A; Sumara I; Sumara G; Kassiri Z; David JP; Bakiri L; Sasse B; Idarraga MH; Rath M; Kurz D; Theussl HC; Perriard JC; Backx P; Penninger JM; Wagner EF
    Genes Dev; 2005 Jan; 19(2):208-13. PubMed ID: 15655111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
    Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
    Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.
    Xu Z; Mei F; Liu H; Sun C; Zheng Z
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unc-51 like autophagy activating kinase 1 accelerates angiotensin II-induced cardiac hypertrophy through promoting oxidative stress regulated by Nrf-2/HO-1 pathway.
    Zhang A; Wang M; Zhuo P
    Biochem Biophys Res Commun; 2019 Jan; 509(1):32-39. PubMed ID: 30581007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.
    Wessely R; Klingel K; Santana LF; Dalton N; Hongo M; Jonathan Lederer W; Kandolf R; Knowlton KU
    J Clin Invest; 1998 Oct; 102(7):1444-53. PubMed ID: 9769337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2.
    Zhang H; Wang T; Zhang K; Liu Y; Huang F; Zhu X; Liu Y; Wang MH; Tang W; Wang J; Huang H
    Crit Care Med; 2014 May; 42(5):e345-54. PubMed ID: 24448199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocase of Inner Membrane 50 Functions as a Novel Protective Regulator of Pathological Cardiac Hypertrophy.
    Tang K; Zhao Y; Li H; Zhu M; Li W; Liu W; Zhu G; Xu D; Peng W; Xu YW
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28432072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast-mediated pathways in cardiac hypertrophy.
    Fujiu K; Nagai R
    J Mol Cell Cardiol; 2014 May; 70():64-73. PubMed ID: 24492068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.